Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352131
Status:
COMPLETED
Last Update Posted:
2010-03-17
First Post:
2006-07-13
Brief Title:
Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors
Sponsor:
ImmunoGen Inc
Organization:
ImmunoGen Inc
Organization Data
Organization:
ImmunoGen Inc
Class:
INDUSTRY
Study ID:
CDR0000491224
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ImmunoGen Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Clinical Operations
Old Organization:
ImmunoGen Inc